Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 18 (5), 705-22

Polymyalgia Rheumatica

Affiliations
Review

Polymyalgia Rheumatica

Carlo Salvarani et al. Best Pract Res Clin Rheumatol.

Abstract

Polymyalgia rheumatica (PMR) is an inflammatory condition of unknown etiology characterized by aching and stiffness in the shoulder and in the pelvic girdles and neck. In the past, PMR was considered a manifestation of giant cell arteritis (GCA) or a variant of elderly-onset rheumatoid arthritis (EORA). The current diagnostic criteria for PMR were empirically formulated by clinical experts who had studied the disease extensively. Arthroscopic, radioisotopic and magnetic resonance imaging studies all have indicated the presence of a synovitis in proximal joints and periarticular structures. The synovitis is probably responsible for the musculoskeletal symptoms in PMR. The prominence assigned to the proximal symptoms has probably overshadowed the less well recognized and more variable distal musculoskeletal manifestations which are present in about half of the cases. A normal erythrocyte sedimentation rate does not exclude a diagnosis of PMR. C-reactive protein and interleukin-6 seem to be more sensitive indicators of disease activity both at diagnosis and during relapse/recurrence. Corticosteroids are the drugs of choice for treating PMR. A course of treatment of 1-2 years is often required. However, some patients have a chronic, relapsing course and require low doses of corticosteroids for several years. Large, multicenter, double-blind, placebo-controlled studies are required to define the role of methotrexate and anti-TNF-alpha agents as corticosteroid-sparing drugs in PMR.

Similar articles

  • Peripheral Musculoskeletal Manifestations in Polymyalgia Rheumatica
    F Ceccato et al. J Clin Rheumatol 12 (4), 167-71. PMID 16891918.
    Fifty-one percent of the patients with PMR presented distal musculoskeletal manifestations, with peripheral synovitis being the most frequent one. Patients with PMR with …
  • [Polymyalgia Rheumatica]
    P Kaposi Novák et al. Orv Hetil 147 (37), 1791-802. PMID 17131799. - Review
    Polymyalgia rheumatica is a disorder that affects people over 50 years of age. The etiology of the disease has not been hitherto clarified exactly. Its incidence among pe …
  • The Spectrum of Conditions Mimicking Polymyalgia Rheumatica in Northwestern Spain
    MA Gonzalez-Gay et al. J Rheumatol 27 (9), 2179-84. PMID 10990231.
    Polymyalgia symptoms are not uncommon as presenting manifestations of a wide spectrum of conditions. Special concern about the presence of diseases different from PMR or …
  • Polymyalgia Rheumatica
    MR Lestico et al. Clin Pharm 12 (8), 571-80. PMID 8222521. - Review
    The epidemiology, relationship to giant cell arteritis (GCA), pathogenesis, pathology, clinical and laboratory features, differential diagnosis, and treatment of polymyal …
  • [Polymyalgia Rheumatica and Giant Cell Arteritis: Recent Data and Current Situation]
    N Announ et al. Rev Med Suisse 4 (149), 696-8, 701. PMID 18472729. - Review
    Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are two frequently linked inflammatory diseases of the elderly. The diagnosis of GCA is based on temporal arte …
See all similar articles

Cited by 18 PubMed Central articles

See all "Cited by" articles

Substances

Feedback